News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24669)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (2)
2 (8)
3 (239)
4 (237)
5 (215)
6 (254)
7 (91)
8 (4)
9 (4)
10 (258)
11 (248)
12 (223)
13 (237)
14 (120)
15 (9)
17 (67)
18 (307)
19 (282)
20 (283)
21 (121)
22 (2)
23 (8)
24 (291)
25 (323)
26 (288)
27 (305)
28 (141)
29 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
23
24
25
26
27
28
29
Bio NC
Smart Insulin Patch Could Revolutionize Diabetes Treatments
The experimental patch monitors glucose levels and has doses of insulin pre-loaded in micro-needles.
February 5, 2020
·
2 min read
·
Alex Keown
Biotech Bay
Aimmune to Advance Development of Newly-Licensed Asset with $200 Million Investment from Nestle
Aimmune announced a licensing deal with Xencor for the investigational humanized monoclonal antibody XmAb7195, which has been redubbed AIMab7195.
February 5, 2020
·
3 min read
·
Alex Keown
Business
Healx appoints Dr Anthony Hall as Chief Medical Officer
Findacure co-founder will apply extensive drug repurposing and rare disease expertise to progress Healx’s drug candidates into the clinic.
February 5, 2020
·
3 min read
Deals
Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding
Founded by UKI2S with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products
February 5, 2020
·
6 min read
Job Trends
Targeting Chronic Infections and Deadly Bacteria
A University of Houston engineering professor is examining the life cycle of stubborn, drug-resistant persister cells in recurrent infections to find a way to destroy them.
February 5, 2020
·
2 min read
Business
Accumen’s 3DR Labs Partners with Resonance Health to Expand its MRI Analysis Services
3DR Labs will employ Resonance Health’s FerriSmart® software to analyze liver iron concentrations from MRIs and provide summary reports
February 5, 2020
·
5 min read
Business
Democratic Lawmakers Chant in Support of Drug Pricing Bill During State of the Union
Chants of “H.R. 3” broke out in the House of Representatives chamber during Tuesday night’s State of the Union Address as Democratic lawmakers urged action on the bill passed late last year that could impact the price of prescription medications paid for by government-funded health programs.
February 5, 2020
·
3 min read
·
Alex Keown
Policy
China’s Wuhan Institute Files to Patent the Use of Gilead’s Remdesivir for Coronavirus
The Wuhan Institute of Virology, part of the China Academy of Sciences, has applied to patent the use of Gilead Sciences’ remdesivir to treat the current coronavirus outbreak.
February 5, 2020
·
3 min read
·
Mark Terry
Active Biotech Pivots Away from MS and Huntington’s Disease, Goes in New Direction
Active Biotech announced that its board of directors has approved the company’s new direction. The focus is on the company’s wholly-owned lead assets, laquinimod and tasquinimod.
February 5, 2020
·
3 min read
·
Mark Terry
Business
BioSpace Global Roundup: Feb. 6
Pharma and life science companies from across the globe provide updates on their pipelines and businesses.
February 5, 2020
·
5 min read
·
Alex Keown
Previous
2 of 22
Next